Gulf International Bank UK Ltd Has $4.84 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Gulf International Bank UK Ltd lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 1.1% during the 4th quarter, Holdings Channel reports. The firm owned 16,125 shares of the company’s stock after selling 185 shares during the period. Gulf International Bank UK Ltd’s holdings in HCA Healthcare were worth $4,839,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of HCA. MML Investors Services LLC increased its stake in HCA Healthcare by 31.7% in the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock valued at $7,241,000 after purchasing an additional 4,285 shares in the last quarter. Meritage Group LP bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at $150,548,000. Galvin Gaustad & Stein LLC bought a new position in HCA Healthcare during the fourth quarter worth about $18,044,000. Alpha DNA Investment Management LLC bought a new stake in shares of HCA Healthcare in the third quarter worth about $869,000. Finally, NRI Wealth Management LC bought a new position in shares of HCA Healthcare during the 4th quarter valued at about $2,896,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 0.2 %

HCA Healthcare stock opened at $320.55 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The firm has a market capitalization of $79.60 billion, a PE ratio of 14.59, a P/E/G ratio of 1.10 and a beta of 1.64. The company’s 50-day moving average is $315.11 and its 200-day moving average is $349.91.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the company posted $5.90 earnings per share. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a $0.72 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.90%. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio is currently 13.11%.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on HCA. Truist Financial dropped their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. KeyCorp cut their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Raymond James lowered HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Finally, StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.